(Q86838813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Isosorbide-5-nitrate sustained-release pellets - an example of computer-supported drug development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

H Zerbe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

V Luckow

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

W Cawello

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Cordes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

30-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

[Rapid attenuation of effects of isosorbide dinitrate during long-term treatment of chronic congestive heart failure]

1 March 2020

cites work

1 reference

12 December 2020

[Reconstruction of dissolution profiles of microcapsulated formulations by the mean and variance of dissolution times (author's transl)]

1 reference

12 December 2020

Conception of peroral sustained-release dosage forms: calculation of initial and maintenance dose with consideration of accumulation

1 reference

12 December 2020

Pharmacokinetics of isosorbide-5-mononitrate after oral and intravenous administration in patients with liver cirrhosis: first results.

1 reference

12 December 2020

Per cent absorbed time plots derived from blood level and/or urinary excretion data

1 reference

12 December 2020

Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man

1 reference

12 December 2020

Tolerance to isosorbide dinitrate: rate of development and reversal

1 reference

12 December 2020

Newer aspects of the pharmacokinetics of organic nitrates

1 reference

12 December 2020

Isosorbide 5‐mononitrate pharmacokinetics in humans

1 reference

12 December 2020

Determination of isosorbide dinitrate and its mononitrate metabolites in human plasma by high-performance liquid chromatography-thermal energy analysis

1 reference

12 December 2020

Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease

1 reference

12 December 2020

Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate

1 reference

12 December 2020

Pharmacokinetic criteria for the evaluation of retard formulations.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016314005874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272511%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference